[RGLS] QoQ Quarter Result on 31-Mar-2018 [#Q1]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
10-May-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q1]
Profit Trend
QoQ- -10.92%
YoY- 19.96%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Revenue 18 18 18 18 18 18 18 0.00%
PBT -8,502 -10,273 -13,847 -16,024 -14,506 -15,835 -21,736 -46.42%
Tax 61 201 118 1 -58 -7 -128 -
NP -8,563 -10,273 -13,847 -16,025 -14,448 -15,828 -21,608 -45.95%
Tax Rate - - - - - - - -
Total Cost 8,581 10,291 13,865 16,043 14,466 15,846 21,626 -45.91%
Ratio Analysis
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
NP Margin -47,572.22 -57,072.22 -76,927.78 -89,027.78 -80,266.67 -87,933.33 -120,044.44 -45.95%
Per Share
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
EPS -9.75 -11.80 -15.93 -18.49 -16.68 -21.09 -48.76 -65.70%
EPS Diluted -9.75 -11.80 -15.93 -18.49 -16.68 -21.09 -48.76 -65.70%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.